Articles

Tenax Therapeutics Stock Craters 90% After Phase 3 Trial Misses Primary Endpoint
Tenax Therapeutics closed at $13.45 on Friday. It opened Monday at $1.77. In between, the company’s only Phase 3 trial reported a treatment difference of 3.5 meters on its primary endpoint, a result so far from significance that seven Wall… Continue Reading

First Phosphate Elevates ADR Listing to Nasdaq Global Market as Two Clean Energy Stocks Diverge on Fresh Disclosures
A Quebec phosphate developer just added a major U.S. exchange to its growing list of listings, the fourth market where its shares now trade. A thermal energy storage company just shrank its share count for the third time in seven… Continue Reading

Montage Gold’s Koné Mine Runs 3 Months Ahead of Schedule
Montage Gold’s mill installation at its flagship Koné project finished three months ahead of schedule. So did the classification area. The company says 81% of an $885 million construction budget is already committed, and first gold is still on track… Continue Reading

Quantum Computing Inc. Revenue Surges to $5.6 Million, Plus Another Tech Stock Move
Quantum Computing Inc. booked $61,000 in revenue a year ago. It just reported $5.6 million for the same quarter this year, alongside a $73.1 million acquisition it completed without pausing to catch its breath. A France-based software company that helps… Continue Reading

Centrus Energy Signs Definitive HALEU Supply Deal With X-Energy
Centrus Energy signed a nuclear fuel contract on August 6 that does not require anyone to guess what “de-risking” means: X-Energy is prepaying for enrichment services it has not received yet, and Centrus is building capacity based on money already… Continue Reading

Faeth Therapeutics Jumps 18% as Cash Grows to $186 Million
Faeth Therapeutics and Veru posted double-digit stock gains on the same Monday, for reasons that had nothing to do with each other. Faeth used its quarterly numbers to show it is sitting on nine times the cash it had six… Continue Reading

Thune Files Cloture on Clarity Act, Sets September 15 Senate Vote
Senate Majority Leader John Thune filed cloture on the Clarity Act at 4:52 AM ET on Saturday, the tail end of an overnight session that ran past the chamber’s scheduled Friday departure for August recess. It is the first time… Continue Reading

Neptune Digital Assets Sells Free Ionic Digital Shares for $234,000
A Vancouver crypto holding company just turned a free stock windfall into over two hundred thousand dollars without spending a cent to acquire it. In Toronto, a fintech company that posted its first-ever profitable quarter this spring just raised its… Continue Reading

IsoEnergy Forms $105M-Backed DISA Uranium Venture as Two Clean Energy Stocks Slide on Fresh Disclosures
A Toronto uranium miner just handed off a chunk of its Utah portfolio to a brand-new company backed by $105 million from strategic investors including a mining major and an oilfield services giant. A battery materials company’s own financing announcement… Continue Reading

BriaCell’s FDA Clearance for Bria-PROS+ Adds a Fourth Active Immunotherapy
BriaCell just added a fourth active immunotherapy program to a pipeline that already has one candidate in Phase 3. The FDA didn’t blink. Two names covered here last week did get their answers this week, and the answers landed nothing… Continue Reading

Alchemy Labs Expands ExoShield to the Ford F-Series, Plus Two Other Small-Cap Tech Moves
Alchemy Labs went public less than a month ago selling windshield film and defense coatings out of the same balance sheet, and it just added one of the best-selling trucks in North America to its customer list. A post-quantum cybersecurity… Continue Reading

Canada Nickel Wins Crawford Approval, Extends Loan for Third Time
Canada Nickel received the first mining approval issued under Canada’s amended Impact Assessment Act on July 31, an approval the company says clears the way toward $70 billion in GDP contribution over the life of its Crawford project. Three days… Continue Reading

Capricor’s Deramiocel Voted Down 9-3 by FDA Advisory Panel
Nine advisory committee members looked at the same trial data Capricor called a win and voted against it. The 9-3 result on July 29 didn’t kill Capricor’s Duchenne muscular dystrophy program, but it added a real question mark to a… Continue Reading

SunPower’s Q2 Revenue Falls 23% on Self-Imposed Quality Holds
SunPower held back $15.3 million of already-signed, already-financed jobs from its own second quarter, on purpose, over blurry photos and missing utility bills. The company reported the results anyway on July 28. Revenue came in at $56.0 million, down 23%… Continue Reading

Strategy’s $8.22B Loss and Coinbase’s Record Market Share
Strategy and Coinbase reported second-quarter earnings within hours of each other on July 30. Strategy’s loss ran into the billions, almost entirely a paper markdown on bitcoin it has no plans to sell. Coinbase’s loss was smaller and came with… Continue Reading

America’s Antimony Push Gets a Pilot Plant. One Junior Is Already Finding More
The U.S. Army and Idaho National Laboratory opened a modular pilot plant in Idaho Falls built to process antimony, a mineral used in ammunition, batteries, and flame retardants that the United States currently gets almost entirely from China and Russia.… Continue Reading

FinWise Bancorp Q2 Profit Falls 22% After Tallied Technologies Buy
A bitcoin miner born out of one of crypto’s ugliest bankruptcies just staged the biggest direct listing Nasdaq has seen in five years. Two days later, a small Utah bank holding company reported its profit fell by more than a… Continue Reading

Nextech3D.ai Signs Definitive Agreement to Acquire Remaining ARway Shares
Nextech3D.ai spent the week finalizing terms to buy the 60% of ARway it doesn’t already own, a company that logged its first profitable quarter less than a year ago. Alset AI Ventures spent the week paying someone $5,000 a month… Continue Reading

Get more visibility
We understand where markets talk, who controls attention, and how public companies gain visibility without damaging credibility.




















